Related Experiment Video
Updated: Mar 31, 2026

09:18
Author Spotlight: Assessing the Reliability of Doppler Ultrasound in Measuring Leg Blood Flow
Published on: December 15, 2023
3.7K
Is there value in the Relative Value Study? Caution before Australian Medicare reform
1University of Technology Sydney, Sydney, NSW michael.wright@chere.uts.edu.au.
The Medical Journal of Australia
|October 15, 2015
Summary
The government
Area of Science:
- Health Policy
- Health Economics
- Medical Services Administration
Background:
- The Medicare Benefits Schedule (MBS) is undergoing its most significant review in 50 years.
- The last major reform attempt, the Relative Value Study (RVS), occurred between 1994 and 2001 but was never implemented.
- Understanding past implementation failures is crucial for current healthcare reform.
Purpose of the Study:
- To provide a historical account of the Relative Value Study (RVS).
- To analyze the reasons for the RVS's implementation failure using health policy theory.
- To inform the current Medicare Benefits Schedule (MBS) Review Taskforce.
Main Methods:
- Historical narrative analysis of the RVS.
- Application of health policy theory to explain implementation challenges.
- Review of government and medical profession collaboration during the RVS period.
Main Results:
- The RVS, a comprehensive review of MBS services and fees, was never implemented.
- Specific methodological difficulties and broader healthcare reform challenges contributed to the RVS's failure.
- Lessons learned from the RVS can guide the current MBS review.
Conclusions:
- The failure to implement the RVS highlights the complexities of health policy reform.
- Analyzing the RVS's historical challenges offers valuable insights for the current Medicare review.
- Successful implementation of the current MBS review may depend on addressing past difficulties.
More Related Videos
Related Concept Videos
Relative Risk
2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
536
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
536
Bioavailability Study Design: Absolute Versus Relative Bioavailability
555
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
555
Bioequivalence Data: Statistical Interpretation
327
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
327
P-value
9.4K
P-value is one of the most crucial concepts in statistics.
P-value stands for the probability value. P-value is the probability that, if the null hypothesis is true, the results from another randomly selected sample will be as extreme or more extreme as the results obtained from the given sample.
A large P-value calculated from the data indicates to not reject the null hypothesis. But a higher P-value does not mean that the null hypothesis is true. The smaller the P-value, the more...
P-value stands for the probability value. P-value is the probability that, if the null hypothesis is true, the results from another randomly selected sample will be as extreme or more extreme as the results obtained from the given sample.
A large P-value calculated from the data indicates to not reject the null hypothesis. But a higher P-value does not mean that the null hypothesis is true. The smaller the P-value, the more...
9.4K
Regression Toward the Mean
7.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
![Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F67458.jpg&w=3840&q=50)
